SEARCH

SEARCH BY CITATION

Abstract

Therapeutic trials in muscular dystrophy have often been inconclusive. A protocol has been designed which selects patients with Duchenne muscular dystrophy and permits accurate measurement of their status. An integral part of the protocol is a system for checking on the consistency of the data obtained using a computer program.